CLS begins evaluation of new thermal therapy system

By staff writers

October 27, 2021 -- Image-guided focal laser ablation technology developer Clinical Laserthermia Systems (CLS) said that its new Transberg thermal therapy system is now being evaluated for use in MRI/ultrasound fusion-guided focal laser ablation of prostate tumors.

In a 10-patient clinical trial, researchers at Germany's Otto von Guericke University Magdeburg are assessing Transberg's performance in providing fusion-guided focal laser ablation therapy for early-stage prostate cancer, according to the vendor.

Copyright © 2021
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking